STORE Capital (NYSE: STOR) and Biomed Realty Trust (NYSE:BMR) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for STORE Capital and Biomed Realty Trust, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STORE Capital 0 5 9 0 2.64
Biomed Realty Trust 0 0 0 0 N/A

STORE Capital presently has a consensus price target of $26.91, suggesting a potential upside of 3.70%. Given STORE Capital’s higher possible upside, equities research analysts clearly believe STORE Capital is more favorable than Biomed Realty Trust.

Insider & Institutional Ownership

95.7% of STORE Capital shares are held by institutional investors. 0.9% of STORE Capital shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares STORE Capital and Biomed Realty Trust’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
STORE Capital 35.67% 5.35% 2.82%
Biomed Realty Trust 18.98% 3.73% 2.07%

Dividends

STORE Capital pays an annual dividend of $1.24 per share and has a dividend yield of 4.8%. Biomed Realty Trust pays an annual dividend of $1.04 per share and has a dividend yield of 4.4%. STORE Capital pays out 139.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Biomed Realty Trust pays out 100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. STORE Capital has increased its dividend for 7 consecutive years. STORE Capital is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation and Earnings

This table compares STORE Capital and Biomed Realty Trust’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
STORE Capital $376.34 million 13.10 $123.32 million $0.89 29.16
Biomed Realty Trust N/A N/A N/A $1.04 22.89

STORE Capital has higher revenue and earnings than Biomed Realty Trust. Biomed Realty Trust is trading at a lower price-to-earnings ratio than STORE Capital, indicating that it is currently the more affordable of the two stocks.

Summary

STORE Capital beats Biomed Realty Trust on 10 of the 12 factors compared between the two stocks.

STORE Capital Company Profile

STORE Capital Corporation is an internally managed net-lease real estate investment trust. The Company is engaged in the acquisition, investment and management of single tenant operational real estate (STORE) properties. As of December 31, 2016, the Company owned a portfolio that consisted of investments in 1,660 property locations operated by 360 customers across 48 states. Its customers operate across a range of industries within the service, retail and manufacturing sectors of the United States economy, with restaurants, early childhood education centers, movie theaters, health clubs and furniture stores. The Company’s portfolio includes investments in approximately 1,330 property locations operated by over 300 customers across approximately 50 states. The Company provides real estate financing solutions principally to businesses that own STORE properties and operate within the broad-based service, retail and industrial sectors of the United States economy.

Biomed Realty Trust Company Profile

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company’s properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Receive News & Ratings for STORE Capital Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STORE Capital Corporation and related companies with MarketBeat.com's FREE daily email newsletter.